Mc. Galas et Tk. Harden, CYCLIC AMP-INDUCED DESENSITIZATION OF G-PROTEIN-REGULATED PHOSPHOLIPASE-C IN TURKEY ERYTHROCYTE-MEMBRANES, European journal of pharmacology, 314(1-2), 1996, pp. 157-164
The interaction of the cyclic AMP and inositol lipid signalling system
s was studied in turkey erythrocytes. Elevation of intracellular cycli
c AMP concentrations by pretreatment of the cells with forskolin or 8-
Br-cAMP resulted in a marked decrease in responsiveness of phospholipa
se C to G-protein activators in membranes prepared from treated cells.
Decreases in responsiveness occurred with a t(1/2) of approximately 5
min and were reversible after transfer of desensitized cells to drug-
fret medium. Pretreatment of the cells with forskolin inhibited inosit
ol phosphate formation in a concentration-dependent manner and additio
n of the phosphodiesterase inhibitor IBMX (3-isobutyl-1-methylxanthine
) during pretreatment increased the capacity of forskolin to desensiti
ze phospholipase C activity. IBMX also produced a similar potentiation
of forskolin-stimulated accumulation of cyclic AMP in turkey erythroc
ytes. Isoproterenol pretreatment of the cells induced, like forskolin,
partial inhibition of inositol phosphate generation in response to G-
protein activators and to P-2Y purinoceptor and beta-adrenoceptor agon
ists. The capacity of isoproterenol to induce desensitization of phosp
holipase C activity also was increased by the presence of IBMX during
pretreatment of the cells. H8 2-(methylamino)ethyl]-5-isoquinoline-sul
fonamide), an inhibitor of cyclic AMP-regulated protein kinase, comple
tely prevented forskolin-induced desensitization but only partially bl
ocked isoproterenol-induced desensitization. These results indicate th
at the cyclic AMP signalling cascade has a major inhibitory influence
on receptor- and G-protein-activated inositol lipid signaling.